Similarly, in the APP/PS1 mouse model of AD (APPswe/PSdE9 double transgenic mice), activation of the Wnt/β-catenin pathway via optogenetic stimulation of LRP6 (an upstream regulator of Wnt signaling) restored BBB function and ameliorated AD pathology [119]. Here, APP is linked to Alzheimer disease.